DJIA 17,289.02 23.03 0.13%
NASDAQ 4,572.92 -20.51 -0.45%
S&P 500 2,011.18 -0.18 -0.01%
market minute promo

Incyte Corp (NASDAQ: INCY)

48.49 -0.39 (-0.80%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INCY $48.49 -0.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $49.29
Previous Close $48.88
Daily Range $48.40 - $49.72
52-Week Range $33.01 - $70.86
Market Cap $8.2B
P/E Ratio -56.84
Dividend (Yield) $0.00 (0.0%)
Volume 360,998
Average Daily Volume 791,201
Current FY EPS -$0.32

Sector

Healthcare

Industry

Drugs

Incyte Corp (INCY) Description

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Website: http://www.incyte.com/

News & Commentary

3 Longtime Losers About to See Green?

These 3 biotechs have lost tons of money every year so far in the 21st century. But could profits be on the horizon?

Incyte: Increasing Sales, Deep Pipeline, Multiple Catalysts, With A Side Of M&A Chatter

Analyst Sees Incyte Worth 70% More

SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks

Gilead: Let's Make A Deal

Earnings Estimates Moving Higher for Incyte Corporation (INCY): Time to Buy? - Tale of the Tape

Earnings Estimates Moving Higher for Incyte Corporation (INCY): Time to Buy? - Tale of the Tape

Bullish Two Hundred Day Moving Average Cross - INCY

3 Drugs Stocks Dragging The Industry Down

Incyte Posts Wider-than-Expected Q2 Loss, Raises Sales View - Analyst Blog

Incyte Posts Wider-than-Expected Q2 Loss, Raises Sales View - Analyst Blog

Incyte's (INCY) CEO Hervé Hoppenot on Q2 2014 Results - Earnings Call Transcript

Q2 2014 Incyte Corp Earnings Conference Call (Webcast)

See More INCY News...

INCY's Top Competitors

INCY $48.49 (-0.80%)
Current stock: INCY
AMGN $143.58 (1.10%)
Current stock: AMGN
GILD $105.92 (-0.01%)
Current stock: GILD
BIIB $327.99 (-0.61%)
Current stock: BIIB